MABXIENCE RESEARCH SL.
Location
Madrid
Founded
2015-12-23
Website
Risk Signals
16 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MABXIENCE RESEARCH SL.
Live alerts from global media, monitored by Business Radar
2025-05-26 (informatori.it)
Abogen and Mabxience together to bring a new biosimilar to Italy <
Abiogen Pharma and Mabxience have announced the signature of a strategic agreement for the marketing in Italy of a biosimilar candidate. According to the terms, abogen will manage marketing and distribution on… Continued
Read more
2021-04-09 (citeline.com)
Mabxience Allies With Zentiva For European Bevacizumab Launch
Mabxience and Zentiva have partnered to launch the Alymsys bevacizumab biosimilar rival to Avastin that recently received a pan-European marketing authorization.
Read more